In a declaration, supported by various Latin American groups, IDPC calls for a new focus in drug policies that encompasses social development, education, universal healthcare, and human rights and fundamental freedom.
This briefing provides an overview of the current discussion around threshold quantities and explores the mechanism of threshold quantities including their benefits and drawbacks as a policy and legal tool.
This briefing paper provides an overview of issues related to kratom legislation and policy in Thailand as well as a set of conclusions and recommendations to contribute to a reassessment of the current ban on kratom in Thailand and the region.
The South East European Drug Policy Network held its third meeting in Thessaloniki, Greece in March 2011, during which participants shared knowledge and experiences from across the region, and identify common problems and key priorities for drug policy advocacy.
With over two years in office, the Obama Administration has had time to begin to make its mark on the government's domestic and international drug policies. This briefing paper analyses the modest changes that have taken place to date.
This report aims to provide the reader with a summary of what happened at 54th Session of the Commission on Narcotic Drugs, including at various satellite events, and offers some analysis of the key discussions and debates.
Last January, IDPC organised its first drug policy seminar in the Middle East and North Africa region, in collaboration with its local partner, the National Rehabilitation Centre, in order to generate constructive discussions and sgare experience on drug policy, and to discuss the possibility to establish a regional network on drug policy.
Since its creation in 2007, IDPC has become a dynamic collaborative initiative which has gradually expanded both its membership and activities to influence national and international drug policies and programmes. This is the first IDPC progress report, which aims to highlight IDPC's key activities and successes since its creation four years ago.
In 2010, observers of the UK heroin scene noticed signs of disruption in the normally well-supplied and efficiently administered UK heroin market. IDPC has been monitoring the situation closely, both in the UK and continental Europe. This briefing paper provides an overview of the European situation, describes the responses of authorities and users, and analyses its possible causes and future development.
This paper examines why the vision of the architects of the global prohibition regime has not been achieved, but also goes on to describe the damage to human health and welfare that has arisen from badly conceived and implemented drug control policies and programmes. The concluding section lays out the broad options that policy makers face for a future ‘direction of travel’.
This Guide has been prepared by IDPC to provide logistical and practical information to our members and partners who are sending participants to attend the 2011 CND.